New Animal Drugs For Use In Animal Feeds; Tylosin

Samenvatting

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, Division of Eli Lilly and Co. The supplemental NADA provides for use of tylosin Type A medicated articles to make Type C medicated swine feeds for prevention and/or control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis.